Miss Dikshyanta Rana

  • Research Associate (Health Economics & Health Technology Assessment)

telephone: +44(0)141 330 6613
email: Dikshyanta.Rana@glasgow.ac.uk
pronouns: She/her/hers

1 Lilybank Gardens, Glasgow, G12 8RZ

Import to contacts

ORCID iDhttps://orcid.org/0000-0001-9133-3094

Biography

Dikshyanta joined the Health Economics and Health Technology Assessment (HEHTA) team in 2018. She has experience in performing economic evaluations alongside clinical trials, decision-analytic modeling, linked health data analysis, and evidence synthesis. To date, her research has centered around the development and application of HTA methodologies in various fields, including cardiovascular diseases, learning disabilities, oncology, and women's health.

She represents our early career researchers (ECRs) in the Scottish Health Economics Early Career (SHEEC) network.

Dikshyanta holds an MSc in Health Economics from the University of York. Her MSc placement was at the Mental Health and Addiction Research Group (MHARG), University of York. She obtained an undergraduate degree in BA (Hons) Economics, with Psychology and Sociology as additional subjects, from Christ University, India in 2016.

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2020
Number of items: 16.

2023

Westrop, S. C., Rana, D. , Jaiswal, N. , Wu, O. , Mcgarty, A. M. , Melville, C. , Ells, L., Lally, P., McEwan, M. and Germeni, E. (2023) Supporting active engagement of adults with intellectual disabilities in lifestyle modification interventions: A realist evidence synthesis of what works, for whom, in what context and why. Journal of Intellectual Disability Research, (Accepted for Publication)

Rana, D. et al. (2023) Lifestyle modification interventions for adults with intellectual disabilities: systematic review and meta-analysis at intervention and component levels. Journal of Intellectual Disability Research, (Accepted for Publication)

Rana, D. et al. (2023) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: a mixed-methods systematic review. Health Technology Assessment, (Accepted for Publication)

Falkowski, A. et al. (2023) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, 117(2), pp. 104-119. (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (PMCID:PMC9970250)

2022

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818) (PMCID:PMC9082260)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

2021

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

Quin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, 10, 251. (doi: 10.1186/s13643-021-01808-0) (PMID:34544482) (PMCID:PMC8453997)

2020

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Online, 9 July 2020.

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

This list was generated on Sun Feb 25 07:50:54 2024 GMT.
Number of items: 16.

Articles

Westrop, S. C., Rana, D. , Jaiswal, N. , Wu, O. , Mcgarty, A. M. , Melville, C. , Ells, L., Lally, P., McEwan, M. and Germeni, E. (2023) Supporting active engagement of adults with intellectual disabilities in lifestyle modification interventions: A realist evidence synthesis of what works, for whom, in what context and why. Journal of Intellectual Disability Research, (Accepted for Publication)

Rana, D. et al. (2023) Lifestyle modification interventions for adults with intellectual disabilities: systematic review and meta-analysis at intervention and component levels. Journal of Intellectual Disability Research, (Accepted for Publication)

Rana, D. et al. (2023) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: a mixed-methods systematic review. Health Technology Assessment, (Accepted for Publication)

Falkowski, A. et al. (2023) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, 117(2), pp. 104-119. (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (PMCID:PMC9970250)

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818) (PMCID:PMC9082260)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

Quin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, 10, 251. (doi: 10.1186/s13643-021-01808-0) (PMID:34544482) (PMCID:PMC8453997)

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Research Reports or Papers

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Conference or Workshop Item

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Online, 9 July 2020.

This list was generated on Sun Feb 25 07:50:54 2024 GMT.

Teaching

Dikshyanta is involved in a range of teaching activities within HEHTA.

She co-leads the Health Economics for HTA module in our online MSc Health Technology Assessment programme. Additionally, she supervises MSc HTA and Master of Public Health (MPH) students. She also tutors on our continuous professional development (CPD) courses.

In the past, Dikshyanta has contributed to the development and delivery of courses for our Future Learn micro-credentials course 'Introduction to Health Economics & Health Technology Assessment'. Furthermore, she has been involved in the Better Health Programme (BHP) - Philippines, which was funded by the U.K. Foreign Commonwealth and Development Office Prosperity Fund in partnership with PricewaterhouseCoopers (PwC) and FHI 360.